机译:成功治疗严重的新诊断的免疫血小板减少症,涉及肺泡出血,组合疗法组合疗法组成,由Romiplosim,Rituximab和Vincristine组成
Division of Hematology Niigata Univerisity Medical and Dental Hospital Japan;
Division of Bone Marrow Transplantation Niigata University Medical and Dental Hospital Japan;
Division of Hematology Niigata Univerisity Medical and Dental Hospital Japan;
Division of Hematology Niigata Univerisity Medical and Dental Hospital Japan;
Division of Hematology Niigata Univerisity Medical and Dental Hospital Japan;
Division of Hematology Niigata Univerisity Medical and Dental Hospital Japan;
Division of Hematology Niigata Univerisity Medical and Dental Hospital Japan;
Division of Hematology Niigata Univerisity Medical and Dental Hospital Japan;
Division of Hematology Niigata Univerisity Medical and Dental Hospital Japan;
Division of Hematology Niigata Univerisity Medical and Dental Hospital Japan;
Division of Hematology Niigata Univerisity Medical and Dental Hospital Japan;
Department of Transfusion Medicine Niigata University Medical and Dental Hospital Japan;
Division of Hematology Niigata Univerisity Medical and Dental Hospital Japan;
Division of Bone Marrow Transplantation Niigata University Medical and Dental Hospital Japan;
Diffuse alveolar hemorrhage; ITP; Romiplostim; Thrombopoietin receptor agonist;
机译:由罗米洛司汀,利妥昔单抗和长春新碱组成的联合疗法成功治疗涉及肺泡出血的严重新诊断的严重免疫性血小板减少症
机译:成功的新诊断严重的伴有肺泡出血的免疫性血小板减少合并罗米普司汀,利妥昔单抗和长春新碱的联合疗法
机译:成功治疗严重的新诊断的免疫血小板减少症,涉及肺泡出血,组合疗法组合疗法组成,由Romiplosim,Rituximab和Vincristine组成
机译:EGCG和DAC组合治疗对治疗三重阴性乳腺癌的影响及辅助免疫检查点梗阻疗法
机译:新诊断或持续性免疫性血小板减少症(ITP)长达1年的成年患者和慢性ITP超过1年的成年患者中的Romiplostim:来自已完成romiplostim研究的综合数据的亚组分析
机译:成功治疗严重的新诊断的免疫血小板减少症,涉及由Romiplosim,Rituximab和Vincristine组合的组合疗法的肺泡出血